Literature DB >> 14739492

"Honeycomb Golgi" in pituitary adenomas: not a marker of gonadotroph adenomas.

Toshiaki Sano1, Rene Mader, Sylvia L Asa, Zhi Rong Qian, Akiko Hino, Shozo Yamada.   

Abstract

The vacuolar change in Golgi complexes known as "honeycomb Golgi" has been described as the ultrastructural hallmark of a specific tumor that has been called the "female gonadotroph" adenoma of the human pituitary. Recently, a few adenomas presenting with Cushing's disease have been reported to exhibit this feature. To clarify the significance of a "honeycomb Golgi" in the classification of pituitary adenomas, we studied clinically nonfunctioning adenomas with or without "honeycomb Golgi" using immunohistochemistry for adenohypophysial hormones and RT-PCR for the cell-specific transcription factors Tpit that identifies corticotrophs and SF-1 that identifies gonadotrophs. All adenomas were from women. Among 20 adenomas with complete "honeycomb Golgi" change, gonadotrophin subunits were totally immunonegative, but ACTH was positive in a few cells of 12 adenomas. Among eight adenomas with partial vacuolar change of the Golgi complex, five were positive for gonadotrophins and two were positive for ACTH. A subgroup of these lesions were examined by RT-PCR and among eight adenomas with typical "honeycomb Golgi" one case expressed both Tpit and SF-1, probably due to contamination with normal pituitary and another expressed neither Tpit nor SF-1. Of the remaining six cases, Tpit was expressed in two cases and SF-1 in four. These findings indicate that "honeycomb Golgi" change can been seen in corticotroph adenomas as well as gonadotroph adenomas. The reason why this vacuolar change occurs only in females remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14739492     DOI: 10.1385/ep:14:4:363

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  10 in total

1.  Clinico-pathological study of Cushing's disease with large pituitary adenoma.

Authors:  H Ikeda; T Yoshimoto; Y Ogawa; K Mizoi; O Murakami
Journal:  Clin Endocrinol (Oxf)       Date:  1997-06       Impact factor: 3.478

2.  A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins.

Authors:  B Lamolet; A M Pulichino; T Lamonerie; Y Gauthier; T Brue; A Enjalbert; J Drouin
Journal:  Cell       Date:  2001-03-23       Impact factor: 41.582

3.  A case of non-functioning pituitary adenoma with Cushing's syndrome upon recurrence.

Authors:  S Yokoyama; Y Kawahara; T Sano; M Nakayama; S Kitajima; J Kuratsu
Journal:  Neuropathology       Date:  2001-12       Impact factor: 1.906

4.  Pituitary adenoma with "honeycomb Golgi" appearance showing a phenotypic change at recurrence from clinically nonfunctioning to typical Cushing disease.

Authors:  Toshiaki Sano; Kalman Kovacs; Sylvia L Asa; Shozo Yamada; Naoko Sanno; Shunichi Yokoyama; Hiroshi Takami
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 5.  Ultrastructural markers in the pathologic diagnosis of pituitary adenomas.

Authors:  E Horvath
Journal:  Ultrastruct Pathol       Date:  1994 Jan-Apr       Impact factor: 1.094

6.  Sex-linked ultrastructural dichotomy of gonadotroph adenomas of the human pituitary: an electron microscopic analysis of 145 tumors.

Authors:  G Kontogeorgos; E Horvath; K Kovacs
Journal:  Ultrastruct Pathol       Date:  1990 Nov-Dec       Impact factor: 1.094

7.  Gonadotroph adenomas of the human pituitary: sex-related fine-structural dichotomy. A histologic, immunocytochemical, and electron-microscopic study of 30 tumors.

Authors:  E Horvath; K Kovacs
Journal:  Am J Pathol       Date:  1984-12       Impact factor: 4.307

8.  Simian virus 40 T antigen-induced gonadotroph adenomas: a model of human null cell adenomas.

Authors:  T R Kumar; K E Graham; S L Asa; M J Low
Journal:  Endocrinology       Date:  1998-07       Impact factor: 4.736

9.  Cushing's disease due to female gonadotroph adenoma of the pituitary.

Authors:  H Ikeda; T Yoshimoto; K Kovacs; E Horvath
Journal:  Clin Endocrinol (Oxf)       Date:  1995-09       Impact factor: 3.478

10.  Steroidogenic factor 1 (SF1) is essential for pituitary gonadotrope function.

Authors:  L Zhao; M Bakke; Y Krimkevich; L J Cushman; A F Parlow; S A Camper; K L Parker
Journal:  Development       Date:  2001-01       Impact factor: 6.868

  10 in total
  6 in total

1.  Co-localization of honeycomb golgi and ACTH granules in a giant ACTH-producing pituitary adenoma.

Authors:  Kyongsong Kim; Shozo Yamada; Masaaki Usui; Toshiaki Sano
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 2.  Subclinical hyperfunctioning pituitary adenomas: the silent tumors.

Authors:  Odelia Cooper; Shlomo Melmed
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.690

3.  The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas.

Authors:  Hiroshi Nishioka; Naoko Inoshita; Ozgur Mete; Sylvia L Asa; Kyohei Hayashi; Akira Takeshita; Noriaki Fukuhara; Mitsuo Yamaguchi-Okada; Yasuhiro Takeuchi; Shozo Yamada
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

Review 4.  Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review.

Authors:  Fabienne Langlois; Dawn Shao Ting Lim; Chris G Yedinak; Isabelle Cetas; Shirley McCartney; Justin Cetas; Aclan Dogan; Maria Fleseriu
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

5.  Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.

Authors:  Odelia Cooper; Anat Ben-Shlomo; Vivien Bonert; Serguei Bannykh; James Mirocha; Shlomo Melmed
Journal:  Horm Cancer       Date:  2010-04       Impact factor: 3.869

6.  Primary Intracranial Neuroendocrine Tumor of the Skull Base Complicated with Tension Pneumocephalus after Radiotherapy.

Authors:  Atsushi Kambe; Sadao Nakajima; Kei Fukushima; Minoru Mizushima; Makoto Sakamoto; Yasushi Horie; Masamichi Kurosaki
Journal:  NMC Case Rep J       Date:  2021-09-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.